If/When Eli Lilly and AstraZeneca put out a viable Covid-19 solution in October, it won’t come as a surprise to DARPA.
The Department of Defense agency that ‘gifted’ the original Internet (ARPANET) to the world back in the 70s, set up the Pandemic Prevention Program (P3) shortly after Donald J. Trump’s presidential inauguration in January 2017. The highly ambitious principle function of P3 is to scramble scientists, pharmacies, and government agencies to combat pandemic outbreaks before they can savage a population. They want to be able to take any virus and come up with “a functionally integrated platform to deliver pandemic prevention treatments in <60 days.”
The process works like this: Grow a virus, find an antibody, evolve antibody. manufacture and deliver a solution. Here is their own explanation in detail and with illustrations. The P3 has been up and running for more than two years already. Working with partners, such as Lilly, AbCellera, AstraZeneca, GlaxoSmithKline, Genentech, and Amgen, they’ve conducted ‘war games’ against viruses, which are simulations of pandemics with their amped-up responses. Ostensibly, the system would be the solution.
As it turned out, an intergovernmental working group set up by the Department of Health and Human Services was there and ready. Officers of the DHHS’s Assistant Secretary of Preparedness and Response (ASPR) team took the first blood sample obtained from a Washington state patient who recovered from COVID-19 and, on February 25, handed it over to a DARPA partner, the privately held biotech company Abcellera in Vancouver, to immediately “evolve identified antibodies to high potency” in order to “deliver gene-encoded therapeutics.” Abcellera partnered with the pharmaceutical giant Eli Lilly to deliver the immune-reactive solution to the public. And on June 1, right as they said they could do, Abcellera and Lilly announced a viable stop-gap solution for Covid-19, pending a vaccine. Ta-da!
Describing how it works, Abcellera tells us that “LY-CoV555 is a highly potent, neutralizing IgG1 monoclonal antibody that targets the spike protein of SARS-CoV-2, the novel coronavirus that causes COVID-19. Its mechanism of action is designed to block viral attachment and entry into human cells, and to neutralize the virus, potentially preventing and treating COVID-19.” In short, LY-CoV555 creates an immune response that wards off Covid-19 as it tries to latch on. However, according to the government, the trial will not end, and outcomes known, until November 5 — just after the election. Meaning antibody treatments could begin in early November.
I have been corresponding with DARPA and Abcellera over the last few months regarding P3. Here is a condensed and lightly edited version of my more recent Q and A with DARPA:
Q: I’m amazed by a process that can identify candidate antibodies that quickly. Can you explain in layman’s terms how that works?
A: The P3 performers used proprietary microfluidic technologies to rapidly screen and select candidate antibodies.
Q: How could P3 be so sure that they’d meet the target of Aug 1, for testing?
A: Where science is concerned, you can never be certain that you will hit a milestone until proven, but based on the data received by that point we were fairly confident that we would meet the deadline.
Q: Can you confirm that the Solution will be distributed first to health workers (I realize the testing is being primarily in high risk environments).
A: Yes, it is our goal to have antibodies available for front line workers first, including healthcare workers, service members, and those with the most medical need.
Q: Is it repeatable? Once it wears off in weeks or months, can said subject repeat the dose and get relief again? (This would be an excellent universal Solution to get everybody back to work again – and to vote, while we are all waiting for a vaccine to be developed.)
A: One advantage of the gene-based platform capability is that it can be re-administered (no vector-based immune response). As a reminder, these are for near immediate, non-permanent protection and are not meant to be a replacement for vaccines.
Q: Following on from my assumption above, can this Solution be a stop-gap measure to get us to the vaccine? If so, how would that work?
A: Correct. The gene-encoded medical countermeasure provides protection in less than three days, but lasts only for months not days, and is not meant to be a replacement for vaccines. It’s a prophylactic for temporary protection before a vaccine is available or an immune response [is elicited].
Q: Assuming the tests go well, how long will it take for FDA approval? Will that process be accelerated? And what is the target date for actual public access to the antibody regimen solution?
A: We have no way of knowing how long it will take for FDA review. That process and timeline are up to the FDA, and DARPA — nor any other government agency — does not have the ability to request accelerated review.
Probab;y the most important Answer above is DARPA’s indication that the antibody treatment, though it stays in the bloodstream for only months, is re-administrable. It is an apparently solid “prophylactic” means of getting the masses to a vaccine. (Good way of making some money, too.)
Though DARPA claims that no accelerated review of data can be had — it would require breaking long-established clinical testing protocols — in a separate ‘miracle’ program run by DHHS, Operation Warp Speed, AstraZeneca is claiming it will have a vaccine available by October. The announcement, released back in May to little fanfare in the MSM, starts:
Responding to President Trump’s call to develop 300 million doses of SARS-CoV-2 vaccine by January under Operation Warp Speed, the U.S. Department of Health and Human Services (HHS) and AstraZeneca are collaborating to make available at least 300 million doses of a coronavirus vaccine called AZD1222, with the first doses delivered as early as October 2020.
Just in time for the election, one hopes. You know, a feel-good October Surprise for a change.
But not so fast. Operation Warp Speed isn’t even mentioned at AstraZeneca’s website. And even though the NYT reported on OWS a week before DHHS posted the above announcement, the paper of record was quick to point out that even getting the vaccine to market by January 2021 was absurd, given that “the fastest a new vaccine has been developed and distributed is four years and most have taken considerably longer.” The Times does not mention the more ambitious October date.
The head of OWS is Dr. Moncef Slaoui, a PhD in molecular biology and immunology. The Trump appointee was brought in because he is seen as a can-do kind of guy. His past work has included a $100m neuroscience research project in Shanghai. And he has called for more cooperation and pooling of resources among Big Pharma companies in situations, such as cancer and Covid-19, where the profit motive should be put aside for the public interest. Sounds good, but let’s not forget his personal ties to Big Pharma through GlaxoSmithKline and Moderna. These are potential conflicts of interest.
In 2013 article for HuffPost, “It’s Time to Further Incentivize Medical Innovation,” Slaoui called for three main changes to standard procedures:
1) Incentivize pre-competitive research
2) Incentivize antibiotics [and viral] discovery and development
3) Incentivize innovation by extending market exclusivity
He writes, “We need to encourage and develop more public-private partnerships to re-stimulate interest in antibiotics research and create realistic ways of paying for it.” In short, Big Pharma companies won’t “waste” money on R and D for solutions, if they will lose exclusivity to what they’ve developed. This is thought to be one of the reasons why attempts to find a “universal” vaccine has so far failed.
Public-Private partnerships always start out as Good Ship Lollipop enterprises. Feel Good miracle-of-medicine vibes are sugarplummed out to delight our belief in Man and our forward progress through history routine. However, Americans are capitalists, too. When we aren’t feeling good about our wonderfulness in the world, we like to make a buck. Ike, in his now infamous farewell speech, has duly warned us about the rise of the Military-Industrial Complex. And the public-private partnerships that could do good for humanity, often have secondary agendas, and when things go wrong with money issues, as they inevitably do, the eggheaded partners like to cook the books to cover up how they’ve conned us.
One of the first things likely to happen, and there already signs of it coming into play, are questions about who receives the medicine and how much it will cost — not unrelated questions. AstraZeneca and Eli Lilly, and others, stand to make zillions of dollars for medications they come up with — a lot of it as the result of research largely paid for by taxpayers, through, in this case, DARPA and Operation Warp Speed. There is a question of how much a dose would cost.
A Business Insider piece earlier this year considers that question. Author Zera Sherrell points out an obvious and crucial point: “In a free market, how much a pharmaceutical company charges for a vaccine is mainly determined by how much governments are willing to pay for it.” And there’s the rub to our dream partnership. The exclusivity that the FDA head Slaoui wants to offer could lead to price gouging underwritten by the government. (Psst, if you were clever, you might find yourself investing in Lilly and AstraZeneca stocks right now, no doubt like many a Congressperson.)
It’s clear our technology is getting to that place where we can rapidly respond to pandemics, if we choose to. What Abcellera has already accomplished, without all the details, is close to miraculous — being able to take any virus and come up with “a functionally integrated platform to deliver pandemic prevention
treatments in <60 days.” But the buck stops where the buck stops, and that may be the limit of public service expectations for Big Pharma, even in a pandemic.
Certainly, Mike Davis sees this as a limitation, as he argues in The Monster Enters, “[M]ultinational capital has been the driver of disease evolution” through our continued destruction of our habitat, and “the failure of the pharmaceutical industry to find profit in mass producing lifeline antivirals, new-generation antibiotics, and universal vaccines.” And yet, this is just what DARPA has set up with its P3 apparatus. Rapid response (ka-ching) rather than universal solutions (what are we commies? they might ask).
There appear to be legitimate reasons to be concerned with the Big Pharma companies involved with a solution to the Covid-19 pandemic. AstraZeneca and Eli Lilly, for instance, were caught up in the Iraqi oil-for-food bribery scandal that the UK’s Serious Fraud Office’s investigation was described as “one of the biggest the organisation has ever carried out.” In essence, these companies primed the well to gain exclusive access to the Iraqi marketplace.
Eli Lilly probably requires closer scrutiny than the others, with respect to motivation. They are still remembered on Capitol Hill for the political maneuvering they effected during the late night vote on the creation of national Homeland Security in December 2002, when language was inserted that removed their legal culpability for serious flaws in thimerosal, a mercury-based preservative that Lilly added to children’s vaccines that resulted so many cases of autism that Lilly was facing multiple class action suits. It turned out that
Mitch Daniels, [George W. Bush’s] White House budget director, [was] a former Lilly executive, and the company’s chairman, Sidney Taurel, was appointed just a few months [before to] President Bush’s Homeland Security Advisory Council. George Bush senior, the President’s father, was on the Lilly board in the Seventies.
God only knows what’s under the hood now, with this president in charge, but Operation Warp Speed is a bad harbinger.
One could argue that even Lilly’s Prozac regime is controversial, not only because of the drug’s checkered effectiveness and dangers, but also because its prescriptional distribution by Do-No-Harmers (snark) has seen some pundits and critics and parents and nurses and patients and LEE wonder aloud if kickbacks weren’t behind some of the pushes of the drug. A pattern is established that suggests motives that are less than the family’s reputation for philanthropic largesse — probably well-deserved.
(Still, in researching the Lilly background I admit some dismay at discovering that Eli, a colonel in the Union army during the Civil War moved down to Mississippi after the war and ran a 1200-acre cotton plantation. What’s not answered in the cleaned up accounts I’ve read is who picked the cotton? Did Eli? Or did he hire some newly “freed” slaves to work the future Che T-shirts? Seems unimportant to some people, maybe, it does shine some light on Lilly decision-making practices.)
Sure I’m jaded, but probably the mother of all conflicts of interests — also in the Bush White House — was Dick Cheney’s interests in bombing the shit out of Iraq because he very likely personally gained from it. Just before joining Bush , he was the former CEO of Halliburton, a company that’s like a pocket Marshall Plan you call onto rebuild the blasted out country that needed regime-changing for its own good. His motto: Be the Chaos. Be the Solution.™ This seems irrelevant, but actually it’s right to the point. Now, I’m not arguing that Big Pharma helped put into play Covid-19, the way Cheney was instrumental in bringing about the war crime called Operation Shock and Awe. Next thing we knew, Cheney was trying to take off the Glove. I liked that glove.
Finally, and meanwhile, the smirklesome Viking, Vladimir Putin, is already seemingly interfering with the 2020 election — brazenly offering up his Sputnik (Hmm, Sputnik, Stuxnet, Sputnik ⇒ ?) vaccine for Covid-19, as if to shore up DJ Trump’s reelection campaign. As Putin laughs his ass off, watching us struggle in humiliation as our democracy gets clowned under by our own sober version of Yeltsin (apparently, the Russians can “do stuff” too), will he ride in like a top-naked hero to offer us vaccine shots come October?
You know, so we could make it to the polls safely in November. We wouldn’t want to let Covid-19 disenfranchise folks.
Ikiwa Eli Lilly na AstraZeneca watatoa suluhisho linalofaa la COVID-19 mnamo Oktoba, haitajawa mshangao kwa DARPA. Shirika la Wizara ya Ulinzi la Marekani ambalo lilitoa mtandao wa ARPANET kwa ulimwengu katika miaka ya 1970, lilianzisha mpango wa kuzuia janga la virusi (Pandemic Prevention Program) muda mfupi baada ya Donald Trump kuapishwa kama rais wa Marekani Januari 2017. Kazi ya msingi ya P3 ni kuunganisha wanasayansi, maduka ya dawa, na mashirika ya serikali kupambana na milipuko ya janga kabla hawawezi kuharibu idadi ya watu. "Wanataka kuwa na uwezo wa kuchukua virusi vyovyote na kuja na "" jukwaa la kazi iliyounganishwa kutoa matibabu ya kuzuia janga katika siku 60 "" Mchakato unafanya kazi kama hii: Kukuza virusi, kupata antibodi, kuendeleza antibodi." kutengeneza na kutoa suluhisho. Hapa kuna ufafanuzi wao wenyewe kwa undani na kwa vielezi. P3 imekuwa ikiendesha kwa zaidi ya miaka miwili sasa. Kwa kufanya kazi na washirika, kama vile Lilly, AbCellera, AstraZeneca, GlaxoSmithKline, Genentech, na Amgen, wamefanya "michezo ya vita" dhidi ya virusi, ambayo ni uigizaji wa janga na majibu yao yaliyoimarishwa. Yaonekana, mfumo huo ungekuwa suluhisho. Kwa mujibu wa taarifa hiyo, kikundi cha kazi cha serikali kilichoanzishwa na Wizara ya Afya na Huduma za Binadamu kimekuwa kikijitayarisha. "Wafisa wa DHHS's Assistant Secretary of Preparedness and Response (ASPR) timu walichukua sampuli ya kwanza ya damu iliyopatikana kutoka kwa mgonjwa wa jimbo la Washington ambaye alipona kutoka COVID-19 na, mnamo Februari 25, waliikabidhi kwa mshirika wa DARPA, kampuni ya kibinafsi ya biotech Abcellera huko Vancouver, ""kuendeleza mara moja antibodies zilizotambuliwa kuwa na nguvu ya juu"" ili ""kutuma matibabu ya jeni.""" "Kama walivyosema, ""Tunaweza kufanya hivyo,"" Abcellera na Lilly walitangaza suluhisho la mwisho la Covid-19 hadi chanjo itakapopatikana." Ta-da! "Kama ilivyoelezwa hapo juu, ""LY-CoV-55"" ni antibodi ya IgG1 ya monoclonal yenye nguvu sana, inayolenga protini ya spike ya SARS-CoV-2, coronavirus mpya inayosababisha COVID-19." "Mfumo wake wa vitendo umebuniwa kuzuia viungo vya virusi na kuingia kwenye seli za binadamu, na kuharibu virusi, uwezekano wa kuzuia na kutibu COVID-19 ""Kwa kifupi, LY-CoV-55 inazalisha majibu ya kinga ambayo inazuia COVID-19 wakati inajaribu kuingilia." Hata hivyo, serikali imesema kesi hiyo haitakoma na matokeo yake yatatambuliwa hadi Novemba 5, baada ya uchaguzi. Hii inamaanisha kwamba matibabu ya kingamwili yanaweza kuanza mapema Novemba. """Nimekuwa nikishirikiana na DARPA na Abcellera katika miezi michache iliyopita kuhusu P3." "Hii ni toleo la muhtasari na edited kidogo ya Q yangu ya hivi karibuni na A na DARPA: ""Mimi kushangazwa na mchakato kwamba inaweza kutambua mgombea kingamwili kwamba haraka." Je, unaweza kueleza kwa maneno ya kawaida jinsi hilo linavyofanya kazi? P3 - P3 ni teknolojia ya microfluidic ya kibinafsi ambayo hutumiwa kwa haraka na kuchagua antibodies ya mgombea. "P3 inawezaje kuwa na uhakika kwamba watakutana na lengo la Agosti 1, kwa ajili ya majaribio?""" """Kwa habari ya sayansi, huwezi kuwa na uhakika kwamba utafikia hatua ya mwisho mpaka uthibitishwe, lakini kulingana na data iliyopokelewa kufikia wakati huo tulikuwa na uhakika kwamba tutafikia tarehe ya mwisho." "Amesema: ""Tunaamini kwamba dawa hiyo itatolewa kwa wafanyakazi wa afya, lakini kwa sasa ni vigumu kuifanya kwa watu walio katika mazingira ya hatari." """Lengo letu ni kuwa na antibodies kwa wafanyakazi wa mstari wa mbele kwanza, ikiwa ni pamoja na wafanyakazi wa huduma za afya, wanajeshi, na wale walio na mahitaji makubwa ya matibabu." Swali: Je, inaweza kurudia-rudia? Baada ya kupungua kwa muda wa wiki au miezi, je, mgonjwa huyo anaweza kurudia kipimo hicho na kupata kitulizo tena? (Hii itakuwa suluhisho bora la ulimwengu wote ili kila mtu arudi kazini tena <unk> na kupiga kura, wakati sisi sote tunasubiri chanjo kutengenezwa.) "Kama matokeo ya utafiti, ""Uwezo wa jukwaa la msingi wa jeni ni kwamba inaweza kutolewa tena (hakuna majibu ya kinga ya vector).""" Kwa kumbukumbu, hizi ni kwa ajili ya karibu mara moja, ulinzi wa muda mrefu na hazikusudiwi kuwa mbadala wa chanjo. "Kama tunavyofikiria, ""Mafuniko"" haya yanaweza kuwa hatua ya kukomesha ili kutuongoza kwenye chanjo?" Ikiwa ndivyo, hilo lingefanyaje kazi? J: Ni kweli. "Uchunguzi wa matibabu unaounganishwa na jeni hutoa ulinzi katika muda wa chini ya siku tatu, lakini unaendelea kwa miezi tu, sio siku, na haukusudiwa kuwa mbadala wa chanjo. """ Ni prophylactic kwa ajili ya ulinzi wa muda kabla ya chanjo inapatikana au majibu ya kinga [ni elicited]. "Kama matokeo ya majaribio hayo yatakuwa mazuri, itachukua muda gani kupata idhini ya FDA?""" Je, mchakato huo utaharakishwa? Ni tarehe gani ya kufikia upatikanaji wa jumla wa suluhisho la dawa ya antibody? "Hatuwezi kujua ni muda gani itachukua kwa ajili ya tathmini ya FDA. """ Utaratibu huo na ratiba ni juu ya FDA, na DARPA - wala shirika lingine lolote la serikali - halina uwezo wa kuomba ukaguzi wa haraka. "Hata hivyo, DARPA inaonyesha kwamba ""tiba ya antibody, ingawa inabaki katika mtiririko wa damu kwa miezi tu, inaweza kutumiwa tena.""" Ni njia ya "kuzuia" inayoonekana kuwa thabiti ya kuingiza watu wengi kwenye chanjo. (Njia nzuri ya kupata pesa, pia.) Ingawa DARPA inadai kwamba hakuna marekebisho ya haraka ya data yanaweza kuwa na - inahitaji kuvunja itifaki za majaribio ya kliniki zilizowekwa kwa muda mrefu - katika mpango tofauti wa'muujiza' unaofanywa na DHHS, Operesheni ya Kasi ya Warp, AstraZeneca inadai kuwa itakuwa na chanjo inayopatikana ifikapo Oktoba. "Tangazo hilo, lililotolewa Mei, linaanza kwa ""kuitikia wito wa Rais Trump wa kutengeneza dozi milioni 300 za chanjo ya SARS-CoV-2 ifikapo Januari chini ya Operesheni ya Kasi ya Warp,"" Idara ya Afya na Huduma za Binadamu ya Marekani (HHS) na AstraZeneca wanashirikiana kutoa angalau dozi milioni 300 za chanjo ya coronavirus inayoitwa AZD1222, na dozi za kwanza zitolewa mapema Oktoba 2020." Ni wakati wa uchaguzi, mtu anatumaini. Unajua, kujisikia vizuri Oktoba mshangao kwa ajili ya mabadiliko. Lakini si haraka sana. Operesheni ya Warp Speed haitajwi hata kwenye tovuti ya AstraZeneca. "Na ingawa NYT iliripoti juu ya OWS wiki moja kabla ya DHHS kuchapisha tangazo la juu, karatasi ya rekodi ilikimbilia kuelezea kwamba hata kupata chanjo kwenye soko ifikapo Januari 2021 ilikuwa ya kipumbavu, ikizingatiwa kwamba ""kiwango cha haraka zaidi chanjo mpya imebuniwa na kusambazwa ni miaka minne na wengi wamechukua muda mrefu zaidi.""" Mkurugenzi wa OWS ni Dk Moncef Slaoui, PhD katika biolojia ya molekuli na kinga. Trump amemteua kwa sababu anaonekana kuwa mtu anayeweza kufanya. Kazi yake ya zamani ilijumuisha mradi wa utafiti wa sayansi ya neva wa $ 100m huko Shanghai. "Ameomba ushirikiano zaidi na kuunganisha rasilimali kati ya makampuni makubwa ya dawa katika hali kama vile kansa na COVID-19, ambapo nia ya faida inapaswa kuwekwa kando kwa maslahi ya umma. """ Inasikika vizuri, lakini tusisahau uhusiano wake wa kibinafsi na Big Pharma kupitia GlaxoSmithKline na Moderna. Hizi ni migogoro ya uwezekano wa maslahi. "Katika makala yake ya mwaka 2013 kwa HuffPost, ""It's Time to Further Incentivize Medical Innovation,"" Slaoui aliomba mabadiliko matatu ya msingi katika taratibu za kawaida: 1) Kuchochea utafiti wa kabla ya ushindani; 2) Kuchochea antibiotics [na virusi] ugunduzi na maendeleo ya suluhisho; 3) Kuchochea ubunifu kwa kupanua upendeleo wa soko; ""Tunahitaji kuhamasisha na kuendeleza ushirikiano zaidi wa umma na binafsi ili kuchochea tena maslahi ya utafiti wa antibiotics na kuunda njia za kweli za kulipa." Hii inafikiriwa kuwa moja ya sababu kwa nini majaribio ya kupata chanjo ya "ulimwengu" hadi sasa yameshindwa. Ushirikiano wa umma na binafsi daima huanza kama biashara za Good Ship Lollipop. Hisia nzuri za miujiza ya dawa ni sukari iliyochanganywa ili kufurahisha imani yetu katika Mwanadamu na maendeleo yetu ya mbele kupitia utaratibu wa historia. Hata hivyo, Wamarekani ni wakuu wa uchumi, pia. Wakati sisi si kuhisi vizuri kuhusu ajabu yetu katika dunia, tunapenda kufanya buck. Ike, katika hotuba yake ya kuaga yenye sifa mbaya sasa, ametuhakikishia kwa usahihi juu ya kuongezeka kwa Jumuiya ya Viwanda vya Kijeshi. Ushirikiano wa umma na binafsi ambao unaweza kufanya mema kwa wanadamu, mara nyingi huwa na ajenda za sekondari, na wakati mambo yanapoenda vibaya na masuala ya pesa, kama wanavyofanya bila shaka, washirika wenye akili nzuri wanapenda kupika vitabu ili kuficha jinsi walivyotudanganya. Moja ya mambo ya kwanza ambayo yanaweza kutokea, na tayari kuna ishara za kuanza kucheza, ni maswali kuhusu nani anapokea dawa na ni kiasi gani itagharimu - sio maswali yasiyo na uhusiano. AstraZeneca, Eli Lilly na wengineo wanafanya mamilioni ya dola kwa dawa zao, nyingi kama matokeo ya utafiti ambao umelipwa na walipa kodi, kupitia, katika kesi hii, DARPA na Operesheni ya Kasi ya Warp. Kuna swali la kiasi gani kipimo hicho kingeweza kugharimu. Makala ya Business Insider mapema mwaka huu inachukua swali hilo. "Mwandishi Zera Sherrell anasema: ""Katika soko huru, kiasi ambacho kampuni ya dawa inatoza kwa chanjo huamuliwa hasa na kiasi ambacho serikali iko tayari kulipa." "Uteuzi wa ""mwenyewe"" ambao mkuu wa FDA Slaoui anataka kutoa unaweza kusababisha ushuru wa bei uliopendekezwa na serikali." """Hata hivyo, ikiwa ulikuwa na akili, unaweza kujikuta ukiwekeza katika hisa za Lilly na AstraZeneca sasa hivi, bila shaka kama wabunge wengi." Ni wazi teknolojia yetu inakuja mahali ambapo tunaweza kujibu haraka kwa janga, ikiwa tutachagua. "Kile ambacho Abcellera tayari imefanya, bila maelezo yote, ni karibu na muujiza - kuweza kuchukua virusi vyovyote na kuja na "" jukwaa la kazi iliyounganishwa kutoa matibabu ya kuzuia janga katika siku 60 "" Lakini pesa inasimama ambapo pesa inasimama, na hiyo inaweza kuwa kikomo cha matarajio ya huduma ya umma kwa Big Pharma, hata katika janga." "Mwanasayansi Mike Davis, ambaye anaandika kitabu chake cha The Monster Enteres, anasema: ""Mali nyingi za kimataifa zimekuwa kichocheo cha magonjwa kupitia uharibifu wetu wa kuendelea wa mazingira yetu, na kushindwa kwa viwanda vya dawa kupata faida katika uzalishaji mkubwa wa dawa za kuua virusi, antibiotics za kizazi kipya, na chanjo za ulimwengu.""" Majibu ya haraka (ka-ching) badala ya suluhisho la ulimwengu wote mzima (sisi ni commies? huenda wakauliza). Kuna sababu halali za kuwa na wasiwasi na makampuni makubwa ya dawa yanayohusika na suluhisho la janga la Covid-19. "Kama ilivyoelezwa katika ripoti ya uchunguzi wa Ofisi ya Udanganyifu wa Kubwa ya Uingereza, ""Kampuni hizo zilijitayarisha vizuri kupata upatikanaji wa kipekee wa soko la Iraq.""" Eli Lilly pengine inahitaji uchunguzi wa karibu zaidi kuliko wengine, kuhusiana na motisha. "Wanajulikana sana katika Capitol Hill kwa ""mabadiliko ya kisiasa"" waliofanya wakati wa kura ya usiku juu ya uundaji wa Usalama wa Taifa mnamo Desemba 2002, wakati lugha ilichukuliwa ambayo iliondoa hatia yao ya kisheria kwa kasoro kubwa katika thimerosal, kihifadhi cha mercury ambacho Lilly aliongeza kwenye chanjo za watoto ambazo zilisababisha kesi nyingi za autism ambazo Lilly alikuwa akikabiliwa na suti nyingi za hatua za kikundi." Mitch Daniels, mkurugenzi wa bajeti wa White House, alikuwa mtendaji wa zamani wa Lilly, na mwenyekiti wa kampuni hiyo, Sidney Taurell, aliteuliwa miezi michache tu kabla ya Baraza la Ushauri la Usalama wa Ndani la Rais Bush. George Bush mzee, baba ya Rais, alikuwa kwenye bodi ya Lilly katika miaka ya sabini. Mungu tu anajua nini ni chini ya hood sasa, na rais hii katika malipo, lakini Operesheni Warp Speed ni ishara mbaya. "Mtu anaweza kusema kwamba hata utawala wa Lilly wa Prozac ni utata, sio tu kwa sababu ya ufanisi wa dawa na hatari, lakini pia kwa sababu usambazaji wake wa maagizo na ""Do-No-Harmers"" umeona baadhi ya wataalamu na wakosoaji na wazazi na wauguzi na wagonjwa na LEE wanajiuliza kwa sauti ikiwa kickbacks hazikuwa nyuma ya baadhi ya kusukuma kwa dawa." Mfano ni imara ambayo inapendekeza nia kwamba ni chini ya sifa ya familia kwa ajili ya ukarimu philanthropic <unk> pengine vizuri haki. Hata hivyo, katika utafiti wa historia ya Lilly, mimi kukubali baadhi ya mshangao katika kugundua kwamba Eli, Kanali katika jeshi la Umoja wakati wa Vita vya wenyewe kwa wenyewe, wakiongozwa chini ya Mississippi baada ya vita na kuendesha 1200 ekari pamba shamba. Kile kisichojibiwa katika akaunti zilizosafishwa ambazo nimesoma ni ni nani alichukua pamba? Je, Eli alifanya hivyo? Au je, aliajiri watumwa waliowekwa huru hivi karibuni ili watengeneze mashati ya Che ya wakati ujao? Inaonekana haina umuhimu kwa baadhi ya watu, labda, ni does shine baadhi ya mwanga juu ya Lilly maamuzi ya kufanya mazoea.) "Amesema: ""Hakika mimi ni jaded, lakini labda mama wa migogoro yote ya maslahi - pia katika Bush White House - ilikuwa maslahi ya Dick Cheney katika mabomu shit nje ya Iraq kwa sababu yeye sana uwezekano binafsi alipata kutoka kwake.""" Kabla tu ya kujiunga na Bush, alikuwa Mkurugenzi Mtendaji wa zamani wa Halliburton, kampuni ambayo ni kama mfuko wa Marshall Plan unayoita kujenga upya nchi iliyopigwa na mlipuko ambayo inahitaji mabadiliko ya utawala kwa faida yake mwenyewe. Kauli mbiu yake: Uwe Mvurugo. Kuwa Solution.TM Hii inaonekana yasiyo ya muhimu, lakini kwa kweli ni haki ya uhakika. "Hata hivyo, ""Big Pharma"" haikusaidia kuweka katika mchezo Covid-19, njia Cheney alikuwa instrumental katika kuleta juu ya uhalifu wa vita aitwaye Operesheni Shock na hofu." Jambo la pili tulilijua, Cheney alikuwa akijaribu kuondoa kinga. Nilipenda glavu hiyo. "Mwishowe, wakati huo huo, Viking mwenye tabasamu, Vladimir Putin, tayari anaonekana kuingilia uchaguzi wa 2020 <unk> kwa ujasiri akitoa Sputnik yake (Hmm, Sputnik, Stuxnet, Sputnik <unk>?) " """Tunaomba chanjo ya Covid-19 ili kuimarisha kampeni ya Trump ya kuchaguliwa tena." "Wakati Putin anapocheka, akituona tukipambana kwa aibu wakati demokrasia yetu inashindwa na toleo letu la Yeltsin (inaonekana, Warusi wanaweza ""kufanya vitu"" pia), je, ataingia kama shujaa wa juu-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na-na Kwa hivyo, kwa hivyo, tunaweza kufanya hivyo kwa uchaguzi salama mnamo Novemba. Hatutaki kuruhusu Covid-19 kuwaondoa watu haki zao za kupiga kura.